FDA recall, , Moderate risk
American Red Cross Blood Services Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from donors who provided travel history to a malaria endemic area but were not assessed for residency.
Recall ended Aug 3, 2026. Still check yours.
What happened
The American Red Cross recalled Apheresis Red Blood Cells, Leukocytes Reduced and Red Blood Cells, Leukocytes Reduced on June 18, 2025, because the units were collected from donors who provided travel history to a malaria endemic area but were not assessed for residency. The recall, affecting North Carolina, was added to the FDA's Enforcement Report on August 3, 2026.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Reason: Apheresis Red Blood Cells, Leukocytes Reduced, collected from donors who provided travel history to a malaria endemic area, but were not assessed for residency, were distributed.
- Affected units
- W18122525264200L (double collection); W181225220785008 (double collection); W181225249733009; W18122523798600V (double collection)
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from donors who provided travel history to a malaria endemic area, but were not assessed for residency, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- American Red Cross Blood Svcs
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99392
- Recall numbers
- B-0153-2026 to B-0154-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary


